Physician profile
Gina Wang
NPI 1518673177
$2,248.88
in general payments reported to CMS, 2019-2025
21 companies · $1,495 in 2025
The $1,495 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $240 · 2024: $514 · 2025: $1,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,248.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $327.32 | 2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $282.59 | 2025 | |
| Glaxosmithkline, LLC. | $271.94 | 2023-2025 | Arexvy, Shingrix |
| Kowa Pharmaceuticals America, INC. | $246.58 | 2025 | Zoryve |
| Lilly USA, LLC | $230.31 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Lexicon Pharmaceuticals, INC. | $201.16 | 2024 | Inpefa |
| Verona Pharma, INC. | $128.47 | 2025 | Ohtuvayre |
| Exact Sciences Corporation | $93.59 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $71.88 | 2023-2025 | Gemtesa |
| Sanofi Pasteur INC. | $61.47 | 2023-2025 | |
| Corcept Therapeutics | $48.98 | 2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $45.74 | 2024 | |
| Abbvie INC. | $42.68 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.51 | 2025 | Jardiance |
| Ardelyx, INC. | $30.88 | 2024 | Ibsrela |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $30.83 | 2023 | Adbry |
| Regeneron Healthcare Solutions, INC. | $25.90 | 2023 | Dupixent |
| Alvogen INC | $22.98 | 2024 | Teriparatide |
| Amgen INC. | $18.05 | 2025 | Evenity |
| Merck Sharp & Dohme LLC | $17.79 | 2024 | Gardasil 9, Vaqta, Gardasil |
| Phadia US INC. | $15.23 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.